NasdaqCM - Delayed Quote USD
Nuvectis Pharma, Inc. (NVCT)
9.02
+0.17
+(1.92%)
At close: 4:00:00 PM EDT
9.02
0.00
(0.00%)
After hours: 4:04:00 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 6 | 6 | 6 | 6 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.31 | -0.25 | -0.25 | -0.25 |
| EPS Actual | -0.26 | -0.24 | -0.36 | -0.27 |
| Difference | 0.05 | 0.01 | -0.11 | -0.02 |
| Surprise % | 15.22% | 5.26% | -42.11% | -6.30% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| NVCT | -- | -- | -- | -- |
| S&P 500 | 13.13% | 2.45% | 7.54% | 14.08% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 4/30/2025 |
| Initiated | Maxim Group: Buy | 4/2/2025 |
| Initiated | Laidlaw & Co.: Buy | 3/17/2025 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 2/25/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 8/6/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 5/8/2024 |
Related Tickers
VYNE VYNE Therapeutics Inc.
0.9601
+0.11%
ELDN Eledon Pharmaceuticals, Inc.
2.9900
0.00%
AARD Aardvark Therapeutics, Inc.
11.77
+0.77%
NAUT Nautilus Biotechnology, Inc.
0.7510
-2.72%
ENTX Entera Bio Ltd.
2.1250
+0.24%
SER Serina Therapeutics, Inc.
5.89
-3.76%
FBRX Forte Biosciences, Inc.
12.25
+2.51%
CNTX Context Therapeutics Inc.
0.6685
-4.89%
NERV Minerva Neurosciences, Inc.
1.8000
-2.17%
MTVA MetaVia Inc.
0.7750
+10.71%